FPH.AXライブシグナル | Getagraph.comで利益を最大化

Live Chart Being Loaded With Signals

Commentary (3 5月 2024 @ 15:10):

Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems worldwide...

Stats
本日の出来高	192 911
平均出来高	303 535
時価総額	15.07B
EPS	$0.125 ( 2020-09-29 )
次の収益日	( $0 ) 2024-05-28
Last Dividend	$0.212 ( 2023-06-26 )
Next Dividend	$0 ( N/A )
P/E	62.93
ATR14	$0.0120 (0.05%)

ボリューム相関

長: 0.19 (neutral)

短: -0.43 (neutral)

Signal:(60.219) Neutral

Fisher & Paykel 相関

10 最も正の相関

10 最も負の相関

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Fisher & Paykel 相関 - 通貨/商品

-0.58
( weak negative )

-0.57
( weak negative )

0.00
( neutral )

-0.53
( weak negative )

0.52
( weak )

Fisher & Paykel 財務諸表

Annual	2023
収益:	$1.49B
総利益:	$885.34M (59.54 %)
EPS:	$0.410

FY	2023
収益:	$1.49B
総利益:	$885.34M (59.54 %)
EPS:	$0.410

FY	2022
収益:	$1.52B
総利益:	$938.68M (61.70 %)
EPS:	$0.610

FY	2021
収益:	$1.95B
総利益:	$1.22B (62.76 %)
EPS:	$0.915

Financial Reports:

No articles found.

Fisher & Paykel Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0 (N/A)	$0.165 (N/A)	$0 (N/A)	$0.212 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Fisher & Paykel Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 6.72 - Stable (34.44%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	$0.0500	2002-06-07
Last Dividend	$0.212	2023-06-26
Next Dividend	$0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	42	--
Total Paid Out	$3.24	--
Avg. Dividend % Per Year	0.00%	--
Score	4.12	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	6.72
Div. Directional Score	9.00	--

Next Divdend (Est)
(2024-10-21)

$0.221 Estimate 3.71 %

Dividend Stability

0.30 Very Poor

Dividend Score

4.12

Pay Frequency

Semi-Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for ASX

Symbol	Title	Last dividend	Frequency	Yearly Dividend
HPI.AX	Ex Dividend Junior	2023-06-29	Semi-Annually	0.00%
RMC.AX	Ex Dividend Knight	2023-09-07	Semi-Annually	0.00%
BTI.AX	Ex Dividend Junior	2023-08-21	Sporadic	0.00%
LNK.AX	Ex Dividend Junior	2023-09-05	Semi-Annually	0.00%
SXE.AX	Ex Dividend Knight	2023-09-26	Annually	0.00%
CQE.AX	Ex Dividend Knight	2023-09-28	Quarterly	0.00%
NBI.AX	Ex Dividend Knight	2023-09-01	Bi-Monthly	0.00%
WOR.AX	Ex Dividend Knight	2023-08-29	Semi-Annually	0.00%
EVN.AX	Ex Dividend Knight	2023-08-30	Semi-Annually	0.00%
PIA.AX	Ex Dividend Knight	2023-08-31	Quarterly	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.153	1.500	6.94	10.00	[0 - 0.5]
returnOnAssetsTTM	0.110	1.200	6.34	7.61	[0 - 0.3]
returnOnEquityTTM	0.144	1.500	9.51	10.00	[0.1 - 1]
payoutRatioTTM	0.563	-1.000	4.37	-4.37	[0 - 1]
currentRatioTTM	2.54	0.800	2.29	1.830	[1 - 3]
quickRatioTTM	1.059	0.800	8.48	6.78	[0.8 - 2.5]
cashRatioTTM	0.246	1.500	9.75	10.00	[0.2 - 2]
debtRatioTTM	0.128	-1.500	7.87	-10.00	[0 - 0.6]
interestCoverageTTM	26.34	1.000	1.354	1.354	[3 - 30]
operatingCashFlowPerShareTTM	0.632	2.00	9.79	10.00	[0 - 30]
freeCashFlowPerShareTTM	0.0505	2.00	9.97	10.00	[0 - 20]
debtEquityRatioTTM	0.174	-1.500	9.30	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.601	1.000	3.32	3.32	[0.2 - 0.8]
operatingProfitMarginTTM	0.219	1.000	7.63	7.63	[0.1 - 0.6]
cashFlowToDebtRatioTTM	1.288	1.000	3.95	3.95	[0.2 - 2]
assetTurnoverTTM	0.717	0.800	8.56	6.84	[0.5 - 2]
Total Score				11.27

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	61.27	1.000	3.91	0	[1 - 100]
returnOnEquityTTM	0.144	2.50	9.68	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	0.0505	2.00	9.98	10.00	[0 - 30]
dividendYielPercentageTTM	1.294	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	0.632	2.00	9.79	10.00	[0 - 30]
payoutRatioTTM	0.563	1.500	4.37	-4.37	[0 - 1]
pegRatioTTM	0.817	1.500	7.89	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.230	1.000	6.75	0	[0.1 - 0.5]
Total Score				6.72

Fisher & Paykel

Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems worldwide. It also provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. The company offers Airvo 2, a humidified nasal high flow system; Optiflow, a nasal high flow therapy; and F&P 850 System, a noninvasive and invasive ventilation system. In addition, it provides infant respiratory products, such as resuscitation, continuous positive airway pressure (CPAP) therapy, and nasal high flow therapy products. Further, the company offers hospital products, including humidification products, breathing circuits, chambers, masks, nasal cannulas, surgical, accessories, and interfaces; and homecare products that include masks, CPAP devices, software and data management products, humidifiers, and accessories. Fisher & Paykel Healthcare Corporation Limited was founded in 1934 and is headquartered in Auckland, New Zealand.